The study published in the scientific journal Frontiers in Cell and Developmental Biology addresses an urgent need to develop more personalised therapies that cater to each patient, while reducing the side effects often brought on by a “one size fits all” approach to treatment.
We hope that this and future studies in our lab can help pediatric leukemia patients achieve recovery with minimum possible adverse side effects.
Joan Montero, IBEC.
We hope that this and future studies in our lab can help pediatric leukemia patients achieve recovery with minimum possible adverse side effects.
You can read the impacts in the media here:
- La Vanguardia
Big Vang - La Vanguardia
Sociedad - EFE
- elDiario.es
- La Razón
